NCT04503291

Brief Summary

If surgical treatment is not possible in patients with malignant obstruction in the common bile duct, placing metal stents using endoscopy is a standardized treatment to resolve biliary obstruction. The metal stent is located in the bile duct to cover the stenotic portion by malignant tumors. The lower end of the metal stent can be located inside the common bile duct above the major ampulla or in the duodenum through the major ampulla. These two procedures with supra- or trans-papillary stents are currently being performed in general clinical practices, depending on the preference of the endoscopists. Until now, the comparison of the clinical results of the two procedures has been scarcely studied, and there is no prospective study yet. Therefore, researchers aim to compare the clinical results of two stent procedures through prospective randomized controlled studies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 7, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

January 4, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2023

Completed
Last Updated

July 22, 2022

Status Verified

July 1, 2022

Enrollment Period

2.7 years

First QC Date

July 30, 2020

Last Update Submit

July 19, 2022

Conditions

Keywords

metal stentcommon bile duct obstructionendoscopic retrograde cholangiopancreatography

Outcome Measures

Primary Outcomes (1)

  • Stent function maintenance duration

    jaundice free survival

    through study completion, an average of 1 year

Secondary Outcomes (5)

  • stone or sludge occurrence

    through study completion, an average of 1 year

  • in-stent stenosis or tumor overgrowth

    through study completion, an average of 1 year

  • acute cholangitis occurrence

    through study completion, an average of 1 year

  • stent migration rate

    through study completion, an average of 1 year

  • overall survival

    From date of randomization until the date of date of death from any cause, assessed up to 36 months

Study Arms (2)

supra-papillary metal stent group

EXPERIMENTAL

The distal ends of metal stents are located above the major papilla in the common bile duct.

Procedure: Metal stent placement

trans-papillary metal stent group

ACTIVE COMPARATOR

The distal ends of metal stents are located below the major papilla in the duodenum.

Procedure: Metal stent placement

Interventions

Non-covered biliary metal stents are placed by endoscopy. The distal ends of metal stents are located above the major ampulla in the common bile duct or below the major ampulla in the duodenum.

supra-papillary metal stent grouptrans-papillary metal stent group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with common bile duct obstruction due to malignancy

You may not qualify if:

  • intrahepatic or perihilar bile duct obstruction (except Klatskin type I)
  • patients who have operability or want surgery
  • strictures located within 2 cm from the end of distal common bile duct
  • patients who are not able to undergo endoscopy due to cardiovascular or pulmonary diseases
  • patients whose informed consents are not received
  • patients in whom an endoscope can not access to the ampulla due to anatomical deformity by previous surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jae Hyuck Chang

Bucheon-si, Kyunggi, 14647, South Korea

RECRUITING

Central Study Contacts

Jae Hyuck Chang, Ph, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Assigned groups are secreted to the participant and outcome assessors
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 1. supra-papillary metal stent group 2. trans-papillary metal stent group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 30, 2020

First Posted

August 7, 2020

Study Start

January 4, 2021

Primary Completion

October 1, 2023

Study Completion

December 12, 2023

Last Updated

July 22, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will share

All of the individual participant data collected during the trial, after deidentification.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Immediately following publication. No end date
Access Criteria
* Investigators whose proposed use of the data has been approved by an independent review committee * To achieve aims in the approved proposal * Proposals may be submitted up to 36 months following article publication.

Locations